Abstract
Objectives Bipolar disorder is associated with increased body mass index (BMI), but it remains undetermined if this association is causal and, if so, in which direction it goes. Here, we sought to answer these questions using bidirectional two-sample Mendelian Randomization, a method from genetic epidemiology that uses data from genome-wide association studies (GWAS) to examine whether a risk factor is causal for an outcome.
Methods We used summary statistics from GWAS of bipolar disorder and BMI conducted using data collected by the Psychiatric Genomics Consortium and the UK Biobank, respectively. The genetic instrument for bipolar disorder contained 53 SNPs and explained 0.5% of phenotypic variance, while the genetic instrument for BMI contained 517 SNPs and explained 7.1% of phenotypic variance.
Results We found that a two-fold increase in the genetic liability to bipolar disorder causes a 0.6 (kg/m2) reduction in BMI, which is statistically significant (P=0.009), and predominantly driven by reduced fat mass. Conversely, we found no evidence that BMI causes changes in the risk of developing bipolar disorder (P=0.59).
Conclusion The findings of this study indicate that the increased BMI observed among individuals with bipolar disorder is not a direct consequence of genetic liability to bipolar disorder, but more likely represents the sum of downstream correlates of manifest bipolar disorder, such as side effects of pharmacological treatment, poor diet and sedentary lifestyle, that are all modifiable and could potentially be targeted as part of clinical management.
Competing Interest Statement
SDO received the 2020 Lundbeck Foundation Young Investigator Prize. Furthermore, SDO owns units of mutual funds with stock tickers DKIGI and WEKAFKI, as well as units of exchange traded funds with stock tickers TRET, 2B76, EXH2, QDVE, QDVH, USPY, SADM and BATE. The remaining authors report no conflicts of interest.
Funding Statement
There was no specific funding for this study. SDO is supported by grants from the Novo Nordisk Foundation (grant number: NNF20SA0062874), the Lundbeck Foundation (grant numbers: R358-2020-2341 and R344-2020-1073), the Danish Cancer Society (grant number: R283-A16461), the Central Denmark Region Fund for Strengthening of Health Science (grant number: 1-36-72-4-20), the Danish Agency for Digitisation Investment Fund for New Technologies (grant number 2020-6720) and Independent Research Fund Denmark (grant number: 7016-00048B). These funders had no role in the study design, data analysis, interpretation of data, or writing of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study involves only openly available results from previously published GWAS, that can be downloaded from the Psychiatrics Genomics Consortium (https://www.med.unc.edu/pgc/download-results) and from the Neale Lab (http://www.nealelab.is/uk-biobank), as well as openly available genetic data from the 1000 Genomes Project (https://www.internationalgenome.org).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The GWAS summary statistics can be downloaded from the Psychiatrics Genomics Consortium (https://www.med.unc.edu/pgc/download-results) and from the Neale Lab (http://www.nealelab.is/uk-biobank). Genetic data from the 1000 Genomes Project can be downloaded from the project's website (https://www.internationalgenome.org).
